Home Infusion Therapy Market Size 2024-2028
The home infusion therapy market size is forecast to increase by USD 17.37 billion at a CAGR of 8.12% between 2023 and 2028.
- The market is experiencing significant growth, driven by technological advancements in infusion pumps and remote monitoring devices. These innovations enable improved patient care and expanded therapeutic options.
- However, the market faces challenges, including the high upfront costs associated with infusion pumps and equipment procurement. To address these challenges, collaborations and developments among market players are increasing to provide more affordable and accessible home infusion therapy solutions. This market trends and analysis report delves into these factors, providing insights into the growth prospects and challenges of the market.
What will be the Size of the Home Infusion Therapy Market During the Forecast Period?
- The market encompasses the provision of intravenous (IV) and subcutaneous (SC) infusion services in a home setting. This market caters to various patient populations, including those with geriatric conditions, immune deficiencies, cancer, congestive heart failure, and other chronic diseases. IV therapy, including hydration therapy, chemotherapy, and infusions for endocrinology, represent significant growth areas. Home infusion services enable patients to receive specialized treatments, such as IV hydration therapy, enteral nutrition, and parenteral nutrition, without the need for hospitalization. Technologies like infusion pumps, syringe and needleless connectors, smart pumps, and pressure pumps facilitate safe and efficient home infusion. The market's expansion is driven by an increasing number of specialty drugs, a growing geriatric population, and the need for cost-effective healthcare solutions in both industrialized and non-industrial countries. Home infusion therapy's role in improving patient outcomes and quality of life continues to gain recognition, making it an essential component of modern healthcare. A team of healthcare professionals, including dieticians, ensure the effective delivery of these therapies.
How is this Home Infusion Therapy Industry segmented and which is the largest segment?
The home infusion therapy industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Application
- Anti-infective
- Chemotherapy
- Endocrinology
- Enteral nutrition
- Others
- Product
- Infusion pumps
- Needless connectors
- Others
- Geography
- North America
- US
- Europe
- Germany
- UK
- Asia
- China
- Japan
- Rest of World (ROW)
- North America
By Application Insights
- The anti-infective segment is estimated to witness significant growth during the forecast period.
In the market, anti-infective medications hold significant importance for treating various infectious diseases In the geriatric population and others at home. These medications include antibiotics for bacterial infections like urinary tract infections and skin infections, antivirals for chronic viral infections such as HIV/AIDS and hepatitis, antifungals for serious fungal infections like candidiasis, and antiparasitics for parasitic infections such as malaria and toxoplasmosis. Home infusion therapy offers extended therapy periods outside hospitals, enhancing patient comfort and ensuring medication adherence. IV hydration therapy, a key component of home infusion, is essential for managing conditions like congestive heart failure and immune deficiencies.
IV therapy, including chemotherapy, enteral nutrition, and parenteral nutrition, is crucial in cancer care. Smart pumps and syringe needleless connectors, pressure pumps, and syringes facilitate efficient and safe delivery of these therapies. Home infusion therapy is gaining popularity in non-industrial countries due to its convenience and cost-effectiveness. Dieticians, endocrinologists, and healthcare providers play a vital role in managing and monitoring these therapies. EHR connectivity, drug libraries, and advanced technologies like aducanumab for Alzheimer's disease and smart infusion pumps further enhance the effectiveness and safety of home infusion therapy.
Get a glance at the market report of various segments Request Free Sample
The Anti-infective segment was valued at USD 7.34 billion in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 39% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market size of various regions, Request Free Sample
The North American market for home infusion therapy holds a prominent position globally, driven by advanced healthcare infrastructure, a large patient population with chronic conditions, and high adoption rates of home-based medical treatments. Chronic diseases such as cancer, immune deficiencies, and congestive heart failure are prevalent in this region, increasing the demand for home infusion therapy. Factors fueling market growth include rising healthcare expenditure, growing awareness of home-based care, and favorable reimbursement policies. Home infusion therapies, including IV hydration therapy, enteral nutrition, parenteral nutrition, and chemotherapy, are commonly used to manage conditions like cancer and immune deficiencies. Technologies such as smart pumps, needleless connectors, and pressure pumps enhance the efficiency and safety of home infusion therapy.
The geriatric population, especially men and women, in North America benefits significantly from these therapies. Hospitals and healthcare providers increasingly rely on conventional and smart infusion pumps, EHR connectivity, drug libraries, and advanced technologies to improve patient care and outcomes. Key diseases targeted by home infusion therapy include Alzheimer's disease, tuberculosis, and malaria.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise In the adoption of Home Infusion Therapy Industry?
Technological advancements in infusion pumps and remote monitoring devices is the key driver of the market.
- Home infusion therapy, which includes intravenous (IV) infusion and subcutaneous (SC) administration of medications, fluids, and nutrients, is experiencing significant growth due to technological advancements in infusion pumps and remote monitoring devices. Modern infusion pumps offer precise and programmable delivery, dose customization, flow rate adjustments, and built-in safety mechanisms to enhance patient safety, convenience, and treatment efficacy. The development of portable and wearable pumps enables patients to receive treatment while maintaining mobility and independence. IV therapy is commonly used for conditions such as immune deficiencies, cancer, congestive heart failure, and hydration therapy. In the geriatric population, IV hydration therapy and parenteral nutrition are essential for managing chronic conditions.
- Advanced infusion pumps are also utilized in cancer care, including chemotherapy, enteral nutrition, and parenteral nutrition. Smart pumps with EHR connectivity, drug libraries, and syringe and needleless connectors ensure accurate and efficient medication administration. Pressure pumps and syringe infusion pumps cater to various patient needs. In non-industrial countries, home infusion therapy is gaining popularity due to its cost-effectiveness and convenience. Advancements in infusion technology have led to the development of innovative therapies, such as Aducanumab for Alzheimer's disease and anti-infective therapy for infectious diseases like tuberculosis and malaria. The World Health Organization supports the expansion of home infusion therapy in underserved populations to improve access to essential treatments.
What are the market trends shaping the Home Infusion Therapy Industry?
Increasing developments and collaborations for patient care and therapeutic options is the upcoming market trend.
- The market is experiencing significant developments, driven by technological advancements, evolving patient care models, and expanding therapeutic applications. Notable developments include the collaboration between Fresenius SE and Co. KGaA and Premier, Inc. To negotiate pricing and terms for Ivenix Infusion Systems. This technology aims to enhance infusion pump reliability and usability. Another development is the introduction of a stand-alone platform for home care services by Amedisys Inc. And Option Care Health Inc. In May 2023. This platform aims to streamline home health services delivery. Intravenous (IV) therapy, including hydration therapy and immune deficiencies treatment, is a primary application of home infusion therapy.
- Conditions such as cancer, congestive heart failure, and infectious diseases like tuberculosis and malaria are also addressed through this therapy. Specialties like endocrinology, oncology, and enteral/parenteral nutrition are key areas of focus. Technologies such as syringe drivers, smart pumps, needleless connectors, and pressure pumps are essential components of home infusion therapy. Dieticians and healthcare providers play crucial roles in managing patient care. Chemotherapy, antimicrobial therapy, and Alzheimer's disease treatment, such as Aducanumab, are among the therapeutic options provided through home infusion therapy. The World Health Organization emphasizes the importance of home infusion therapy in addressing healthcare accessibility and affordability concerns in non-industrial countries.
What challenges does the Home Infusion Therapy Industry face during its growth?
High upfront costs associated with infusion pumps and equipment procurement is a key challenge affecting the industry growth.
- Home infusion therapy, which involves the administration of intravenous (IV) infusions, hydration therapy, immune deficiencies treatment, and nutritional support such as enteral and parenteral nutrition, is a vital aspect of healthcare, particularly for managing complex conditions like cancer, congestive heart failure, and immune deficiencies In the geriatric population. The use of IV therapy and subcutaneous (SC) infusions has become increasingly common, with the adoption of advanced technologies like syringe infusers, smart pumps, needleless connectors, and pressure pumps. However, the high upfront costs associated with procuring these devices pose a significant challenge for patients and healthcare providers in non-industrial countries. Infusion pumps are essential for delivering medications, fluids, and nutrients accurately and efficiently In the home setting.
- However, the initial investment required to purchase or lease these devices can be substantial, making it difficult for patients with limited financial resources or inadequate insurance coverage to access this critical care. For those managing chronic illnesses, co-payments, deductibles, and coverage limitations can add to the out-of-pocket costs, even with insurance. Key therapies In the home infusion market include IV hydration therapy, chemotherapy, immune deficiencies treatment, and enteral and parenteral nutrition. Diseases such as cancer, congestive heart failure, and immune deficiencies are common indications for home infusion therapy. In addition, there is a growing need for home infusion therapy In the treatment of Alzheimer's disease with drugs like Aducanumab.
- Other indications include anti-infective therapy for infectious diseases like tuberculosis and malaria, as well as endocrinology treatments. Healthcare providers and patients rely on the expertise of dieticians, nurses, and other healthcare professionals to manage these complex therapies effectively. Smart infusion pumps with EHR connectivity, drug libraries, and other advanced features are increasingly being adopted to improve patient safety, reduce errors, and enhance the overall quality of care.
Exclusive Customer Landscape
The home infusion therapy market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the home infusion therapy market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, home infusion therapy market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.
B.Braun SE - Home infusion therapy, including Digital smart infusion solutions like Space plus and OnlineSuitelus, is gaining prominence for its patient-centric approach. This advanced therapy delivers medication and nutrients directly to patients In their homes, enhancing convenience and improving overall care. Digital smart infusion systems offer advanced features, such as remote monitoring and real-time data analysis, enabling healthcare providers to ensure optimal patient outcomes.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- Bio-Med Pvt. Ltd.
- Cardinal Health Inc.
- Catholic Health Initiatives
- Community Surgical Supply
- Fresenius SE and Co. KGaA
- Health Vista Pvt Ltd.
- Health2home
- ICU Medical Inc.
- Medix Infusion
- Nipro Corp.
- Option Care Health Inc.
- Prochant
- Reviv Genetics Ltd.
- Sober Care Surgical
- UnitedHealth Group Inc.
- University of Pennsylvania Health System
- Walgreens Boots Alliance Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Research Analyst Overview
Home infusion therapy, a medical treatment modality that involves administering medications, fluids, and nutrients intravenously or subcutaneously, has gained significant traction in recent years. This form of therapy offers numerous advantages, particularly for patients with complex medical conditions, such as immune deficiencies, geriatric population, cancer, congestive heart failure, and various other chronic diseases. IV therapy plays a crucial role in managing these conditions, providing essential nutrients and medications directly into the bloodstream. Hydration therapy, a key component of IV therapy, is particularly important for patients suffering from dehydration, which can be a common issue in various disease states. Beyond IV therapy, home infusion therapy also encompasses other modalities like subcutaneous (SC) therapy, which involves administering medications under the skin using a syringe and needle or smart pumps with needleless connectors.
These advanced delivery systems offer increased patient comfort and convenience, making home infusion therapy a more viable option for patients. The market for home infusion therapy is driven by several factors, including the growing prevalence of chronic diseases, an aging population, and advancements in technology. Smart pumps, for instance, offer improved safety, accuracy, and ease of use, making them increasingly popular among healthcare providers and patients. Moreover, the demand for home infusion therapy is not limited to industrialized countries. In non-industrial countries, the need for affordable and accessible healthcare solutions has led to a growing interest in home infusion therapy.
This trend is further fueled by the availability of cost-effective technologies and the increasing recognition of the benefits of home-based care. Home infusion therapy also plays a significant role in various medical specialties, such as endocrinology, oncology, and infectious disease management. For instance, in oncology, home infusion therapy enables patients to receive chemotherapy and other cancer treatments In the comfort of their own homes, reducing the need for frequent hospital visits. Dieticians and healthcare professionals play a crucial role in managing home infusion therapy, ensuring proper patient education, medication administration, and monitoring. In addition, the integration of home infusion therapy with electronic health records (EHR) and drug libraries allows for seamless communication between healthcare services providers and improved patient care.
The market is expected to continue growing, driven by the increasing prevalence of chronic diseases, technological advancements, and the shift towards cost-effective, patient-centric care. As research and development in this field progress, we can anticipate further innovations and advancements that will enhance the efficacy and accessibility of home infusion therapy. In conclusion, home infusion therapy represents a vital component of modern healthcare, offering numerous benefits for patients with complex medical conditions. The market for home infusion therapy is driven by various factors, including demographic trends, technological advancements, and the growing recognition of the importance of patient-centric care. With continued innovation and investment in this field, we can expect home infusion therapy to play an increasingly significant role In the delivery of high-quality, cost-effective healthcare solutions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
158 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.12% |
|
Market growth 2024-2028 |
USD 17.37 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
7.58 |
|
Key countries |
US, Germany, UK, Japan, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Home Infusion Therapy Market Research and Growth Report?
- CAGR of the Home Infusion Therapy industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the home infusion therapy market growth of industry companies
We can help! Our analysts can customize this home infusion therapy market research report to meet your requirements.